Kevin McGill, Associated Press Published 12:00 a.m. ET March 26, 2019

CLOSE

A daily low-dose aspirin has been touted by many doctors in preventing heart attacks. But a new study suggests that it might do more harm than good. Just the FAQs, USA TODAY

NEW ORLEANS – The pharmaceutical companies behind the widely advertised blood thinner Xarelto reached a $775 million settlement in 25,000 lawsuits alleging patients were not adequately warned about the risks of life-threatening complications, plaintiff attorneys and the manufacturers said Monday.

Bayer Healthcare and Janssen Pharmaceuticals had won six of the cases that went to trial. Bayer said in an emailed statement that the settlement “allows the company to

Read More At Article Source | Article Attribution